Related Experiment Video

Updated: Dec 9, 2025

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.3K

The relationship between TRAF6 and tumors

Jiaoduan Li1,2,3,4,5, Nian Liu1,2,3,4,5, Ling Tang1,2,3,4,5

  • 1Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan China.

Cancer Cell International
|September 9, 2020
PubMed

Insights

Tumor necrosis factor receptor-associated factor 6 (TRAF6) is upregulated in many cancers, driving tumor growth and spread. Targeting TRAF6 presents a promising new strategy for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Tumor necrosis factor receptor (TNFR)-related factors (TRAFs) are key signaling molecules.
  • TRAF6 is one of seven TRAF family members.
  • TRAF6 is frequently upregulated in various tumors.

Purpose of the Study:

  • To review and analyze the role of TRAF6 in tumorigenesis and cancer development.
  • To explore TRAF6's oncogenic characteristics and involvement in tumor progression.
  • To discuss TRAF6 as a potential therapeutic target in cancer treatment.

Main Methods:

  • Literature review of studies on TRAF6 and cancer.
  • Analysis of signaling pathways regulated by TRAF6 in tumorigenesis.
  • Synthesis of current research on TRAF6's function in tumor invasion and metastasis.

Main Results:

  • TRAF6 exhibits oncogenic properties, promoting tumor initiation and development.
  • TRAF6 is implicated in tumor invasion and metastasis through diverse signaling pathways.
  • Upregulation of TRAF6 is a common feature in many types of cancer.

Conclusions:

  • TRAF6 plays a critical role in cancer progression.
  • Targeting TRAF6 offers a novel therapeutic strategy for various cancers.
  • Further research into TRAF6 signaling pathways is warranted for effective cancer therapies.
Keywords:
AP-1E3 ubiquitin ligaseNF-κBTRAF6Tumorigenesis

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.6K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.4K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
84.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.6K